Intercell AG - Articles and news items

Merck logo

Merck and Intercell terminate Phase II/III clinical trial of V710

Industry news / 8 June 2011 / Merck

DMC recommends termination of the evaluation of investigational Staphylococcus aureus vaccine, V710…

Staphylococcus aureus

Update on Phase II/III clinical trial of investigational staphylococcus aureus vaccine, V710

Industry news, News / 11 April 2011 / Merck

After a pre-specified interim analysis the DMC has recommended suspension of enrollment…

Bill Gates visited Intercell to discuss vaccine approaches for developing countries

Industry news, News / 20 July 2010 / Capital MS&L

Intercell AG announced that Bill Gates, has visited Intercell’s headquarter for a close look at the Company’s product pipeline and…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...